Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03519984
Title EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute Leukemia
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Southern California
Indications

acute leukemia

Therapies

sEphB4-HSA + Vincristine sulfate liposome

Cytarabine + sEphB4-HSA

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.